The Manufacturers Life Insurance Company cut its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 0.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,801 shares of the real estate investment trust’s stock after selling 308 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Sabra Healthcare REIT were worth $1,200,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Sabra Healthcare REIT by 9.3% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,151 shares of the real estate investment trust’s stock valued at $100,000 after acquiring an additional 352 shares in the last quarter. Daiwa Securities Group Inc. raised its holdings in Sabra Healthcare REIT by 15.7% in the second quarter. Daiwa Securities Group Inc. now owns 5,900 shares of the real estate investment trust’s stock valued at $142,000 after acquiring an additional 800 shares in the last quarter. Riverhead Capital Management LLC raised its holdings in Sabra Healthcare REIT by 96.0% in the second quarter. Riverhead Capital Management LLC now owns 6,861 shares of the real estate investment trust’s stock valued at $165,000 after acquiring an additional 3,361 shares in the last quarter. Flinton Capital Management LLC raised its holdings in Sabra Healthcare REIT by 96.1% in the second quarter. Flinton Capital Management LLC now owns 6,868 shares of the real estate investment trust’s stock valued at $165,000 after acquiring an additional 3,366 shares in the last quarter. Finally, Laurion Capital Management LP acquired a new stake in shares of Sabra Healthcare REIT during the second quarter worth $200,000. 99.26% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT, Inc. (NASDAQ SBRA) opened at $19.46 on Friday. The company has a market cap of $3,468.39, a PE ratio of 8.54, a PEG ratio of 2.52 and a beta of 0.94. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.89. Sabra Healthcare REIT, Inc. has a 12-month low of $19.07 and a 12-month high of $29.10.

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Tuesday, November 14th. This represents a $0.28 annualized dividend and a dividend yield of 1.44%. Sabra Healthcare REIT’s dividend payout ratio is currently 153.19%.

WARNING: This report was originally posted by Watch List News and is owned by of Watch List News. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at https://www.watchlistnews.com/sabra-healthcare-reit-inc-sbra-position-cut-by-the-manufacturers-life-insurance-company/1697565.html.

A number of analysts have weighed in on SBRA shares. BidaskClub raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Wednesday, July 19th. TheStreet cut shares of Sabra Healthcare REIT from a “b-” rating to a “c” rating in a report on Friday, November 3rd. Capital One Financial Corporation started coverage on shares of Sabra Healthcare REIT in a report on Monday, September 25th. They set an “equal weight” rating and a $24.00 target price on the stock. Zacks Investment Research cut shares of Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a report on Wednesday, October 25th. Finally, Stifel Nicolaus reissued a “hold” rating and set a $26.00 target price on shares of Sabra Healthcare REIT in a report on Friday, July 28th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $24.40.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.